GlassScriptPhysician profile
Makoto Ogihara
NPI 1659419380
$1,443.98
in general payments reported to CMS, 2019-2025
10 companies · $368 in 2025
The $368 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $438 · 2020: $107 · 2022: $115 · 2023: $124 · 2024: $292 · 2025: $368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $784.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $784.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $393.39 | 2024-2025 | |
| Intuitive Surgical, INC. | $242.43 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $233.15 | 2022-2024 | Livtencity |
| Mallinckrodt Hospital Products INC. | $183.09 | 2023-2025 | Terlivaz |
| Exelixis INC. | $128.09 | 2019 | |
| Veloxis Pharmaceuticals, INC. | $122.06 | 2019 | |
| Baxter Healthcare | $72.26 | 2025 | |
| Allergan, INC. | $31.32 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $20.85 | 2019 | |
| Ethicon US, LLC | $17.34 | 2023 | Surgicel Nu-Knit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Makoto Ogihara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.